Axicabtagene ciloleucel,Cyclophosphamide,Fludarabine
Gilead
['lymphoma', 'kitepharma', 'gilead']
#news: announcing detailed results from the overall survival analysis of the landmark phase 3 study of #cartcell therapy compared with historical standard of care as initial treatment for relapsed/refractory large b-cell lymphoma. #asco23
Our singular focus is #celltherapy to treat and potentially cure cancer. Guidelines: https://t.co/tweIpVRAGZ